A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity
PHASE1CompletedINTERVENTIONAL
Enrollment
23
Participants
Timeline
Start Date
August 23, 2024
Primary Completion Date
December 18, 2024
Study Completion Date
December 18, 2024
Conditions
Obesity
Interventions
DRUG
Danuglipron
Danuglipron oral tablets
Trial Locations (1)
06511
Pfizer Clinical Research Unit - New Haven, New Haven